Youths prescribed antipsychotics gain body fat, have increased diabetes risk

June 13, 2018, Washington University School of Medicine
Ginger E. Nicol, M.D. Credit: Washington University School of Medicine

Psychiatrists know that patients who take antipsychotic drugs tend to gain weight. Now, new research conducted at Washington University School of Medicine in St. Louis shows that children and adolescents treated with antipsychotics for as little as 12 weeks experience significant gains in body fat and also become less sensitive to insulin.

The findings, from researchers at Washington University and Florida Atlantic University, are published June 13 in the journal JAMA Psychiatry.

Although originally developed and approved to treat conditions such as pediatric-onset schizophrenia, are prescribed to treat attention deficit hyperactivity disorder (ADHD) in many youths who don't respond to stimulant medications, such as Ritalin.

"Antipsychotic medications can be helpful for many as a treatment for behavior disorders," said Ginger E. Nicol, MD, the study's first author and an associate professor of child psychiatry at Washington University. "But we know these drugs also have side effects involving fat gain and insulin resistance, important precursors to diabetes and cardiovascular disease. Our results underscore the need for greater vigilance regarding side effects when prescribing these medications."

The researchers studied 144 St. Louis-area youths, ages 6 to 18, who were prescribed drugs to treat disruptive behavior disorders. Children in the study were chosen randomly to receive one of three antipsychotics: aripiprazole, olanzapine or risperidone.

Using dual-energy X-ray absorptiometry (DEXA) scans, the researchers measured patients' whole body fat before they were prescribed antipsychotic drugs; after six weeks of treatment; and at 12 weeks, when the study concluded. The youths also received MRI scans at the start of the study and 12 weeks later, measuring subcutaneous and visceral fat in the abdomen—known risk factors for diabetes, high blood pressure and cardiovascular disease. The children's sensitivity to insulin also was measured at the beginning and end of the 12-week study period.

"At the start of the study, about 30 percent of the youths in our sample were overweight or obese, which is exactly the same rate we see in the general population," said John W. Newcomer, MD, the study's principal investigator and a professor of integrated medical science at Florida Atlantic University's Charles E. Schmidt College of Medicine. "But after only 12 weeks of treatment, the rate of those considered overweight or obese had risen to 46.5 percent. We essentially went from one in three children meeting criteria for being overweight or obese, to one in two meeting criteria."

One in particular—olanzapine—produced the largest increases in body fat, but fat also increased significantly in children taking the other two medications. The DEXA scans showed that about half of the weight gain was water, and half was new fat.

"We knew these drugs were causing weight gain, but we didn't know how much of that gain was fat," said Newcomer, who also is an adjunct professor of psychiatry at Washington University. "We also knew that children taking antipsychotics had an increased risk of diabetes. But until now, no one had connected those dots through a pathway involving increases in body fat and decreases in insulin sensitivity."

The gains in body fat and losses in insulin sensitivity were observed whether or not the youths were taking stimulant medications. That's despite the fact many children on Ritalin or other stimulants lose weight or grow more slowly than their peers who don't take those drugs.

"Some clinicians hoped that stimulant treatment might offset antipsychotic-induced weight and fat increases," Nicol said. "But in our study, stimulants didn't seem to make any difference."

Because offer psychiatric benefits in many children who are not psychotic but have disruptive behavior disorders, Nicol is studying interventions aimed at helping prevent some of the increases associated with antipsychotic treatment.

"Clinicians are often presented with challenging circumstances where a rapid intervention is needed," she said. "For example, with disruptive behaviors often are suspended from school, and treatment may offer them the ability to return. But the decision to use antipsychotic medications must be fully informed by all of the risks, as well as the potential benefits, of treatment."

Explore further: Use of some antipsychotics during pregnancy may raise risk of gestational diabetes

More information: Nicol GE, Yingling MD, Flavin KS, Schweiger JA, Patterson BW, Schechtman KB, Newcomer JW. Metabolic effects of antipsychotics in children (MEAC): A randomized clinical trial assessing treatment effects on adiposity and insulin sensitivity. JAMA Psychiatry, June 13, 2018. jamanetwork.com/journals/jamap … psychiatry.2018.1088

Related Stories

Use of some antipsychotics during pregnancy may raise risk of gestational diabetes

May 7, 2018
Women who take certain antipsychotic medications and continue the use of these medications through pregnancy may be at increased risk for gestational diabetes, according to new research published online today by the American ...

Antipsychotic drug use in children for mood, behavior disorders increases type 2 diabetes risk

August 21, 2013
Prescribing of "atypical" antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study ...

Anti-psychotics used to manage autism and intellectual disability behaviour can have serious side effects—new study

April 4, 2018
Antipsychotic medication is typically licensed in the UK for people with serious mental health conditions, such as schizophrenia. But in recent years, some antipsychotic drugs have been prescribed more and more "off label". ...

Team identifies weight-gain receptor linked to antipsychotic drugs

August 15, 2017
Many schizophrenic and depressed patients experience weight gain and type 2 diabetes in their quests for the life-changing benefits of a major class of antipsychotic drugs.

Antipsychotics induce insulin resistance without weight gain

July 18, 2013
(HealthDay)—Atypical antipsychotic drugs induce insulin resistance even in the absence of weight gain and mechanisms regulating eating behavior, according to a study published online July 8 in Diabetes.

Antipsychotic prescribing trends in youths with autism and intellectual disability

May 31, 2016
About one in 10 youths treated with an antipsychotic are diagnosed with autism spectrum disorder or intellectual disability. Conversely, one in six youths diagnosed with autism spectrum disorder has been prescribed antipsychotics. ...

Recommended for you

Psychiatric disorders share an underlying genetic basis

June 21, 2018
Psychiatric disorders such as schizophrenia and bipolar disorder often run in families. In a new international collaboration, researchers explored the genetic connections between these and other disorders of the brain at ...

One year of school comes with an IQ bump, meta-analysis shows

June 21, 2018
A year of schooling leaves students with new knowledge, and it also equates with a small but noticeable increase to students' IQ, according to a systematic meta-analysis published in Psychological Science, a journal of the ...

Ketamine acts fast to treat depression and its effects last—but how?

June 21, 2018
In contrast to most antidepressant medications, which can take several weeks to reduce depressive symptoms, ketamine—a commonly used veterinary anesthetic—can lift a person out of a deep depression within minutes of its ...

Mindful movement may help lower stress, anxiety

June 21, 2018
Taking a walk may be a good opportunity to mentally review your to-do list, but using the time to instead be more mindful of your breathing and surroundings may help boost your wellbeing, according to researchers.

Brain tingles—first study of its kind reveals physiological benefits of ASMR

June 21, 2018
Autonomous sensory meridian response (ASMR) – the relaxing 'brain tingles' experienced by some people in response to specific triggers, such as whispering, tapping and slow hand movements – may have benefits for both ...

New study debunks Dale Carnegie advice to 'put yourself in their shoes'

June 21, 2018
Putting yourself in someone else's shoes and relying on intuition or "gut instinct" isn't an accurate way to determine what they're thinking or feeling," say researchers from Ben-Gurion University of the Negev (BGU), the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.